NEWS AND MEDIA

Read our statement on COVID-19

Recent News

Purdue Pharma L.P. Files Broadly Supported Plan of Reorganization

Plan will create National Opioid Abatement Trust Plan will make more than $10 billion in value available for opioid abatement programs across the country 100% of Purdue’s assets will be transferred to a new company dedicated at its core to addressing the opioid crisis…

Purdue Pharma Reaches Agreement With U.S. Department of Justice

-- Agreement resolves DOJ investigations into past marketing practices -- Settlement funds primarily directed to state, local and tribal governments for opioid crisis abatement purposes -- Agreement brings Purdue closer to its ultimate goal of delivering more than $10…

Speaking Out Against Systemic Racism

WE FEEL compelled at this moment to speak out about the unacceptable and disturbing acts of racial injustice that have brought our nation to an inflection point. WE BELIEVE that any form of racism or racial suppression is wrong. We believe that addressing injustice…

Our Commitment to Safety as we Navigate Coronavirus

We have always been guided by our core values—Collaboration, Integrity, Courage, and Innovation—but now, facing the challenges posed by COVID-19, our core values have taken on new meaning. The health and safety of our colleagues, customers and community, along with…

Privacy Policy Updates

Please read carefully the Purdue Pharma L.P. Privacy Policy (the “Privacy Policy”), which is part of the Purdue Pharma L.P. Terms and Conditions, before you access, download, or otherwise use any of our websites, related other parties’ websites, mobile applications, or any electronic service (collectively, the “Service”). This Privacy Policy describes the information collected through Your use of the Service, how we use it, how we share it, how we protect it, and the choices You can make about Your information.